Lonza breaks the mould with microbiological testing kit
A rapid microbial detection kit presented as the only genetic-based test on the market to quantify yeast and mould has been launched by Switzerland's Lonza.
Archives for April 7, 2008
Zogenix $86m IPO to fund needle-free development
Zogenix says that proceeds from a planned $86m initial public offering (IPO) will be used to fund development of its pipeline of needle-free medicines for pain and central nervous system indications.
Invitrogen sues GE Healthcare over patent infringement
Invitrogen has immersed itself in yet more legal wrangling after the life sciences firm filed a patent lawsuit against GE Healthcare alleging 'wilful' infringement of its intellectual property.
Synchron spreading its wings
Synchron Research has revealed it is close to opening up new operations in Vietnam and Hong Kong - within the next six months - and has just bought a new business in France and strengthened its ties with Parexel.
Weekly comment
US still dwarfs the clinical scene, despite offshoring trend
Despite all the hype over clinical trial offshoring, the US still dwarfs the scene, with emerging countries as yet only a blip on the radar, a unique new study reveals.
Olympus centre strengthens R&D in lab equipment
Olympus is planning to expand its European operations with a €15m R&D centre in Munich, Germany, tasked with producing the next generation of in vitro lab diagnostics and laboratory automation equipment.
Malaysia's pharma star set to rise
Malaysia's pharmaceutical star is likely to rise as of this year, with an eventual position being gained amongst some of the world's industry leaders being predicted by Frost & Sullivan.